期刊文献+

不能手术胰腺癌不同治疗模式的预后分析 被引量:1

Prognosis of patients with inoperable pancreatic carcinoma treated by interventional chemotherapy,radiotherapy, or a combination
原文传递
导出
摘要 目的 通过不能手术胰腺癌单纯介入治疗、常规或三维适形放疗、常规或三维适形放疗+介入治疗模式的预后分析,探讨最佳治疗模式.方法 回顾分析2003-2008年收治的139例局部晚期(Ⅲ期,82例)和转移性(Ⅳ期,57例)胰腺癌患者资料,其中胰头癌74例.3例患者穿刺病理诊断为导管腺癌,大多为CT、MRI超声等影像学结合临床症状和化验检查临床诊断.单纯介入治疗、常规或三维适形放疗、常规或三维适形放疗+介入治疗分别为71、34、34例,比较3种治疗模式结果 并行单因素及Cox模型多因素分析.结果 随访率为92.1%,随访满1、2年者分别为115、98例.全组1和2年生存率分别为37.1%和16.3%,局部晚期胰腺癌的分别为44%和20%,单纯介入治疗、常规或三维适形放疗、常规或三维适形放疗+介入治疗的分别为18%和5%、61%和29%、48%和25%(χ2=14.65,P=0.001).全组胰腺癌预后单因素分析有意义因素为分期(χ2=4.49,P=0.035)、是否接受常规或三维适形放疗(χ2=15.32,P=0.000)、肿瘤原发部位(χ2=10.74,P=0.002)等,多因素分析有意义因素为肿瘤原发部位(χ2=5.00,P=0.025)、是否接受常规或三维适形放疗(χ2=7.93,P=0.005).结论 对不能手术的局部晚期胰腺癌患者,常规或三维适形放疗是有效的治疗模式,而常规或三维适形+介入治疗效果还需进一步研究. Objective To analyze the results and prognosis for patients with inoperable pancreatic carcinoma treated by interventional chemotherapy (IC) ,three-dimensional radiotherapy (RT), or IC + RT.Methods From 2003 to 2008,139 patients with locally advanced (82 patients, stage Ⅲ) or metastatic (57 patients, stage Ⅳ) pancreatic cancer were retrospectively analyzed, including 74 with pancreatic head carcinoma (53.2%).Three patients with ductal adenocarcinoma were diagnosed with fine-needle aspiration, all other patients were clinically diagnosed with imagings (CT, MRI and/or ultrasonosraphy),clinical symptoms and tumor markers, There were 71,34 and 34 patients receiving IC alone, 3DCRT alone and 3DCRT plus IC, respectively.Log-rank univariate and Cox model multivariate analyses were used to determine prognostic factors.Results The follow-up rate was 92.1%.115 and 98 patients were followedup longer than 1 and 2 years, respectively.The 1-and 2-year overall survival rates were 37.1% and 16.3%for all patients, 44% and 20% for patients with locally advanced disease.The corresponding rates were 18% and 5%, 61% and 29% ,48% and 25% (χ2= 14.65,P=0.001) for patients receiving IC alone, RT alone, and IC + RT, respectively.In univariate analysis, staging (χ2= 44.49, P = 0.035), radiotherapy (χ2= 15.32, P = 0.000) and tumor location (χ2= 10.741, P = 0.002) were prognostic factors.In multivariate analysis, tumor location (χ2= 5.00, P = 0.025) and radiotherapy (χ2= 7.93, P = 0.005) were prognostic factors.Conclusions Radiotherapy can improve overall survival among patients with inoperable pancreatic cancer.The effect of RT + IC should be further investigated.
出处 《中华放射肿瘤学杂志》 CSCD 北大核心 2010年第5期445-447,共3页 Chinese Journal of Radiation Oncology
关键词 胰腺肿瘤/放射疗法 胰腺肿瘤/化学疗法 化学疗法 介入性 预后分析 Pancreatic neoplasms/radiotherapy Pancreatic neoplasms/chemotherapy Chemotherapy, interventional Prognosis analysis
  • 相关文献

参考文献13

  • 1张思维,陈万青,孔灵芝,李连弟,鲁凤珠,李光琳,孟佳,赵平.中国部分市县1998~2002年恶性肿瘤的发病与死亡[J].中国肿瘤,2006,15(7):430-448. 被引量:171
  • 2Yeo TP,Hruban RH,Leach SD.Pancreatic cancer.Curt Probl Cancer,2002,26:176 -275. 被引量:1
  • 3NCCN clinical practice guidelines in oncology:pancreatic carcinoma[2009-10-21].http://www.nccn.org. 被引量:1
  • 4Crane CH,Varadhachary G,Settle SH.The integration of chemoradiation in the care of patient with localized pancreatic cancer.Cancer Radiother,2009,13:123-143. 被引量:1
  • 5杨红,钱家鸣,张惠广,郭涛.胰腺癌300例临床特点分析[J].基础医学与临床,2007,27(7):815-818. 被引量:8
  • 6张群华,倪泉兴,代表中国抗癌协会胰腺癌专业委员会.胰腺癌2340例临床病例分析[J].中华医学杂志,2004,84(3):214-218. 被引量:142
  • 7Ben-Josef E,Lawrence TS.Chemoradiotherapy for unresectable pancreatic cancer.Int J Clin Oncol,2008,13:121-126. 被引量:1
  • 8Krishnan S,Rana V,Janjan NA.Prognostic factors in patients with unresectable locally advanced pancreatic adenocarcinoma treated with chemoradiation.Cancer,2006,107:2589-2596. 被引量:1
  • 9Magnino A,Gatti M,Massucco P.Phase Ⅱ trial of primary radiation therapy and concurrent chemotherapy for patients with locally advanced pancreatic cancer.Oncology,2005.68:493-499. 被引量:1
  • 10Krishnan S,Rana V,Janjan NA.Induction chemotherapy selects patients with locally advanced,unresectable pancreatic cancer for optimal benefit from consolidative chemorediation therapy.Cancer,2007,110:47-55. 被引量:1

二级参考文献41

  • 1徐勇.Meta分析常见资料类型及统计分析方法[J].中华预防医学杂志,1994,28(5):303-307. 被引量:66
  • 2邓瑞雪,陆星华,王丽,李辉,钱家鸣,杨爱明,钟守先,郭晓钟,周璐,吴晰,杨晓鸥,蒋卫君.建立医院胰腺癌高危评分模型及筛查方案的研究[J].中华医学杂志,2005,85(29):2038-2042. 被引量:11
  • 3全国肿瘤登记中心.中国肿瘤登记工作指导手册[M].北京:中国协和医科大学出版社,2004.48-50. 被引量:5
  • 4Jensen OM,Parkin DM,Maclennan R,et al.Cancer Registration:Principles and Methods[M].Lyon:IARC Scientific Publication No.95,1991. 被引量:1
  • 5Parkin DM,Chen VW,Ferlay J,et al.Comparability and quality control in cancer registration[M].Lyon:IARC Technical Report No.19,1994. 被引量:1
  • 6Felay J,Burkhard C,Whelan S,et al.Check and conversion programs for cancer registries[M].IARC Technical Report No.42,2005. 被引量:1
  • 7Felay J.The IARCcrgTools program.http://www.iacr.com.fr/iarccrgtools.htm.IACR.Lyon.2006. 被引量:1
  • 8Glass GV. Primary,secondary and Meta - analysis of research[J].Educa Res,1976,6(1):3 - 12. 被引量:1
  • 9Burris HA Ⅲ, Moore M J, Andersen J, et al. Improvements in survival and clinical benefit with gemcitabine as first - line therapy for patients with advanced pancreatic cancer:a randomized trial[J]. Clin Oncol,1997,15(5):2403 - 2408. 被引量:1
  • 10Armitage P. Statistic methods in medical research [M]. Oxford:Blackwell scientific Pub, 1983. 370 - 372. 被引量:1

共引文献356

同被引文献10

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部